Prof. Hani Alhadrami has over ten years of academic and community services (with the accomplishment of four USA patents, over 80 publications in high-impact peer-reviewed journals and the establishment of several academic degrees). He is a PI at the Centre of Genomic Medicine Research and the Special Infectious Agent Unit BSL3. He is the founder of the Saudi Society of Molecular Biology & Biotechnology. His research on COVID-19 has remarkable impact worldwide in terms of detection and treatment.
Prof. Hani Alhadrami has been promoted to a full professor in less than ten years since his graduation from the UK. The British education has significantly contributed to his success as a scientist and a leader. His achievements have been widely highlighted on social media and TV channels. He is one of the stakeholders who are forming research rules for the future of KSA and other countries.